MONTREAL, QUEBEC--(Marketwire - March 24, 2008) - Ambrilia Biopharma Inc. (TSX: AMB) today announced its financial results for the fourth quarter and fiscal year ended December 31, 2007, and provided a review of its development programs and upcoming milestones.
